Blood tests may be possible for mental health conditions

Blood tests for panic disorder and other mental health conditions are potentially around the corner, based on results from a University of Iowa study.

The findings, which were based on analysis of genetic information in immature white blood cells, appear online March 6 in the American Journal of Medical Genetics.

"The ability to test for panic disorder is a quantum leap in psychiatry," said the study's lead author, Robert Philibert, M.D., Ph.D., professor of psychiatry in the UI Roy J. and Lucille A. Carver College of Medicine.

"Panic disorder will no longer be a purely descriptive diagnosis, but, as with cystic fibrosis, Down syndrome and other conditions, a diagnosis based on genetic information," he said. "In addition, the finding could help us better understand the pathways that initiate, promote and maintain panic disorder."

The team compared gene expression in lymphoblasts (immature white blood cells) culled from 16 participants with panic disorder and 17 participants without the disorder. The study found many genes were more expressed in people with panic disorder than in people without the condition. Similarly, the study found many genes were less expressed in people with panic disorder. There were also sex-related differences.

Overall, people with panic disorder had noticeably different patterns of gene expression than people without the disorder. Although panic disorder is a disease of brain cells, the study used lymphoblasts as "stand-ins" for the genetic testing because brain cells are not accessible or easily tested.

Approximately 3 percent of people in the United States have panic disorder, which involves having at least one panic attack every four weeks. Panic attacks can involve up to 10 symptoms, including palpitations, shortness of breath, sweating and a feeling of loss of control or dying -- symptoms that are very similar to heart attack symptoms.

"People with panic disorder often end up in the emergency room for heart tests when in fact they have panic disorder. This is just one of the reasons that it would be helpful to have a blood test for panic disorder," Philibert said.

A blood test for commercial use is now being developed by the UI, which raises larger questions about how information revealed by such tests will be used. The issue of patient medical records and how they can potentially be used by employers, insurers, government agencies and other institutions is a concern, Philibert said.

"Science is like a hammer. You can use it to build a house or break a window," Philibert said. "We certainly intend for this finding to help people manage their disease, and when possible, to prevent it from affecting their lives.

"If we can, it could help us identify systems that interact with the environment and possibly lead the way to new, even non-drug, therapies to prevent illness," he added.

Source: University of Iowa

Related stories:

Fear that freezes the blood in your veins
"The blood froze in my veins" or "My blood curdled" – these common figures of speech can be taken literally, according to the latest studies. Indeed, more literally than some of us would like. For it turns out that intense fear and panic attacks can really make our blood clot and increase the risk of thrombosis or heart attack.
Anxiety disorders surprisingly common yet often untreated
A new study by researchers led by Kurt Kroenke, M.D., of the Indiana University School of Medicine and the Regenstrief Institute, Inc. reports that nearly 20 percent of patients seen by primary care physicians have at least one anxiety disorder. The study outlines the effectiveness of a new screening tool which can alert busy primary care physicians to those patients with one or more anxiety disorders. The study is published in the March 6 issue of the Annals of Internal Medicine.
Probing Question: What's killing the honey bees?
Far away from the snowdrifts outside our windows, spring is unfolding in California as the almond trees begin to bloom. Missing from the party are millions of honey bees typically trucked in to pollinate the $2-$3 billion crop.
Scientists show hallucinogen in mushrooms creates universal 'mystical' experience
Using unusually rigorous scientific conditions and measures, Johns Hopkins researchers have shown that the active agent in "sacred mushrooms" can induce mystical/spiritual experiences descriptively identical to spontaneous ones people have reported for centuries.
Fringe autism treatment could get federal study
(AP) -- Pressured by desperate parents, government researchers are pushing to test an unproven treatment on autistic children, a move some scientists see as an unethical experiment in voodoo medicine.
Liver protein associated with type 2 diabetes in older adults
The presence of a protein expressed by the liver which inhibits insulin action may identify individuals more likely to develop type 2 diabetes, according to a new study led by a researcher from the UCSD School of Medicine, to be published July 9 in the Journal of the American Medical Association (JAMA.)
Seizures in newborns can be detected with small, portable brain activity monitors
Compact, bedside brain-activity monitors detected most seizures in at-risk infants, researchers at Washington University School of Medicine in St. Louis showed. That means the compact units could assist clinicians in monitoring for electrical seizures until confirmation with conventional EEG (electroencephalography), the researchers assert in an article published in the June issue of Pediatrics.
Relaxation response can influence expression of stress-related genes
How could a single, nonpharmacological intervention help patients deal with disorders ranging from high blood pressure, to pain syndromes, to infertility, to rheumatoid arthritis? That question may have been answered by a study finding that eliciting the relaxation response – a physiologic state of deep rest – influences the activation patterns of genes associated with the body's response to stress. The collaborative investigation by members of the Benson-Henry Institute for Mind/Body Medicine at Massachusetts General Hospital (MGH) and the Genomics Center at Beth Israel Deaconess Medical Center (BIDMC) appears in the open-access journal PLoS One.

News discussion:

Medicine & Health news